Off-label short-term use of thiocolchicoside (Tiyozid®) in the clinical therapy of fibromyalgia
Summary: Fibromyalgia (FM) is a complex, chronic, nondegenerative musculoskeletal disorder of unknown etiology, and it requires a different clinical approach for every patient. Objectives: The present clinical follow-up observes the effect of the central-acting myorelaxant thiocolchicoside...
Saved in:
Main Authors: | Valentina Reshkova, Simeon Monov, Alexander Mandadjiev |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2025-01-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/117694/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of biomarkers for clinical activity of systemic lupus erhythematodes
by: Valentina Reshkova, et al.
Published: (2025-01-01) -
Stability Studies of Thiocolchicoside in Bulk and Capsules Using RP-HPTLC/Densitometry
by: Dnyansing K. Rajput, et al.
Published: (2013-01-01) -
Think Stop before Going 'Off-Label'
by: Gerald Y Minuk
Published: (2004-01-01) -
Piriformis Syndrome in Fibromyalgia: Clinical Diagnosis and Successful Treatment
by: Md Abu Bakar Siddiq, et al.
Published: (2014-01-01) -
Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report
by: Ruchir Gupta, et al.
Published: (2023-11-01)